NASDAQ · Healthcare · Biotechnology
Adicet Bio, Inc.
ACET
Adicet Bio, Inc. CEO Chen Schor · Market cap $79.8M.
$8.32
-0.23 · -2.69%
52w hi $17.4452w lo $6.01
Off 52w high 54.7%
60
NOTABLE
Current InsiderScore
Corp · 90d
3
3 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
0 strong · 5 notable
Analyst consensus
Strong Buy
Avg PT $18.00
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Feb 20 | RA CAPITAL MANAGEMENT, L.P. | Buy | 74,751 | $7.27 | +$543K | 60 | |
| Feb 19 | RA CAPITAL MANAGEMENT, L.P. | Buy | 74,268 | $7.21 | +$535K | 60 | |
| Feb 18 | RA CAPITAL MANAGEMENT, L.P. | Buy | 74,577 | $7.04 | +$525K | 60 | |
| Oct 08 | ORBIMED ADVISORS LLC | Buy | 1,500,000 | $1.00 | +$1.50M | 66 | |
| Oct 08 | ORBIMED ADVISORS LLC | Buy | 3,500,000 | $1.00 | +$3.50M | 73 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay